Literature DB >> 32305984

Comorbidities in the Elderly and Their Possible Influence on Vaccine Response.

Anja Kwetkat1, Hans Jürgen Heppner2,3.   

Abstract

The following chapter is focused on the impact of comorbidities on the effectiveness of vaccination in older persons. Relevant comorbidities are cardiovascular diseases like hypertension, coronary artery disease or congestive heart failure, which lead to reduction of vaccine immunogenicity; or chronic obstructive pulmonary disease with a decline in lung function and a higher risk for pneumonia or infections due to influenza. End-stage renal disease has a high impact on developing infections and causes immune dysfunction over all parts of the immune system. Depression and dementia as well as psychological stress are associated with poor antibody response and a higher range of inflammation markers. Chronic inflammatory processes like rheumatoid arthritis also alter the immune system. In addition, geriatric syndromes and lowered functional status have implications for the vaccination response. Malnutrition is characterized by depletion of structural and functional proteins. This leads to a low antibody response. Negative immunomodulatory effects are also observed in vitamin D insufficiency. Frailty as well is associated with immunological changes and lowered performance in the activities of daily living, but moderate physical activity improves immune function.
© 2020 S. Karger AG, Basel.

Entities:  

Year:  2020        PMID: 32305984     DOI: 10.1159/000504491

Source DB:  PubMed          Journal:  Interdiscip Top Gerontol Geriatr        ISSN: 2297-3486


  16 in total

1.  Risk for Shoulder Conditions After Vaccination: A Population-Based Study Using Real-World Data.

Authors:  Chengyi Zheng; Jonathan Duffy; In-Lu Amy Liu; Lina S Sy; Wansu Chen; Lei Qian; Ronald A Navarro; Denison S Ryan; Sunhea S Kim; Cheryl Mercado; Steven J Jacobsen
Journal:  Ann Intern Med       Date:  2022-03-22       Impact factor: 25.391

Review 2.  Roadmap for Sex-Responsive Influenza and COVID-19 Vaccine Research in Older Adults.

Authors:  Janna R Shapiro; Rosemary Morgan; Sean X Leng; Sabra L Klein
Journal:  Front Aging       Date:  2022-02-11

3.  Nationwide effectiveness of five SARS-CoV-2 vaccines in Hungary-the HUN-VE study.

Authors:  Zoltán Vokó; Zoltán Kiss; György Surján; Orsolya Surján; Zsófia Barcza; Bernadett Pályi; Eszter Formanek-Balku; Gergő Attila Molnár; Róbert Herczeg; Attila Gyenesei; Attila Miseta; Lajos Kollár; István Wittmann; Cecília Müller; Miklós Kásler
Journal:  Clin Microbiol Infect       Date:  2021-11-25       Impact factor: 8.067

4.  Rapid Detection and Inhibition of SARS-CoV-2-Spike Mutation-Mediated Microthrombosis.

Authors:  Sandro Satta; Angela Lai; Susana Cavallero; Cayden Williamson; Justin Chen; Ana M Blázquez-Medela; Mehrdad Roustaei; Barbara J Dillon; Nureddin Ashammakhi; Dino Di Carlo; Zhaoping Li; Ren Sun; Tzung K Hsiai
Journal:  Adv Sci (Weinh)       Date:  2021-10-23       Impact factor: 17.521

5.  Effectiveness of influenza vaccination in the elderly: a population-based case-crossover study.

Authors:  Chun-Yu Liang; Shinn-Jang Hwang; Kuan-Chia Lin; Chung-Yi Li; Ching-Hui Loh; James Yi-Hsin Chan; Kwua-Yun Wang
Journal:  BMJ Open       Date:  2022-02-21       Impact factor: 2.692

6.  Antibody Responses After mRNA-Based COVID-19 Vaccination in Residential Older Adults: Implications for Reopening.

Authors:  David A Nace; Kevin E Kip; John W Mellors; Octavia M Peck Palmer; Michael R Shurin; Katie Mulvey; Melissa Crandall; Michele D Sobolewski; P Nathan Enick; Kevin D McCormic; Jana L Jacobs; April L Kane; Amy Lukanski; Paula L Kip; Alan Wells
Journal:  J Am Med Dir Assoc       Date:  2021-06-12       Impact factor: 4.669

Review 7.  Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives-A report of the European Academy of Allergy and Clinical Immunology (EAACI).

Authors:  Milena Sokolowska; Zuzanna M Lukasik; Ioana Agache; Cezmi A Akdis; Deniz Akdis; Mübeccel Akdis; Weronika Barcik; Helen A Brough; Thomas Eiwegger; Andrzej Eljaszewicz; Stefanie Eyerich; Wojciech Feleszko; Cristina Gomez-Casado; Karin Hoffmann-Sommergruber; Jozef Janda; Rodrigo Jiménez-Saiz; Marek Jutel; Edward F Knol; Inge Kortekaas Krohn; Akash Kothari; Joanna Makowska; Marcin Moniuszko; Hideaki Morita; Liam O'Mahony; Kari Nadeau; Cevdet Ozdemir; Isabella Pali-Schöll; Oscar Palomares; Francesco Papaleo; Mary Prunicki; Carsten B Schmidt-Weber; Anna Sediva; Jürgen Schwarze; Mohamed H Shamji; Gerdien A Tramper-Stranders; Willem van de Veen; Eva Untersmayr
Journal:  Allergy       Date:  2020-10       Impact factor: 14.710

8.  SARS-CoV-2 Seroconversion and Viral Clearance in Patients Hospitalized With COVID-19: Viral Load Predicts Antibody Response.

Authors:  Mar Masiá; Guillermo Telenti; Marta Fernández; José A García; Vanesa Agulló; Sergio Padilla; Javier García-Abellán; Lucía Guillén; Paula Mascarell; José C Asenjo; Félix Gutiérrez
Journal:  Open Forum Infect Dis       Date:  2021-01-05       Impact factor: 3.835

9.  Short Term Safety, Immunogenicity, and Reproductive Effects of Combined Vaccination With Anti-GnRH (Gonacon) and Rabies Vaccines in Female Feral Cats.

Authors:  Shiri Novak; Boris Yakobson; Shir Sorek; Liat Morgan; Smadar Tal; Ran Nivy; Roni King; Lauren Jaebker; Douglas C Eckery; Tal Raz
Journal:  Front Vet Sci       Date:  2021-05-10

10.  Real-world effectiveness of BNT162b2 mRNA vaccine: a meta-analysis of large observational studies.

Authors:  Chia Siang Kow; Syed Shahzad Hasan
Journal:  Inflammopharmacology       Date:  2021-07-09       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.